Agnes Zak1, Cassandra Corrigan1, Zhi Yu1, Asaf Bitton2, Liana Fraenkel3, Leslie Harrold4, Josef S Smolen5, Daniel H Solomon1. 1. Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, USA. 2. Division of General Medicine, Brigham and Women's Hospital, Boston, MA, USA. 3. Division of Rheumatology, Yale School of Medicine, West Haven Veterans Affairs Health System, New Haven, CT, USA. 4. Department of Orthopaedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, USA. 5. Division of Rheumatology, University of Vienna, Vienna, Austria.
Abstract
Objectives: Adherence to a treat to target (TTT) strategy is a recommended paradigm for RA; however, research shows there are many barriers to implementation. We conducted a trial to improve TTT implementation, and herein examine barriers to treatment adjustment within TTT among patient visits not in agreement with the TTT paradigm. Methods: Chart review assessed TTT implementation based on documentation of four items: designation of a treatment target, recording a disease activity measure, shared-decision making when applicable and adjusting treatment when disease activity was not at target. A treatment decision not in agreement with the TTT paradigm was defined as lack of treatment adjustment when disease activity was not at the pre-determined treatment target. Providers were encouraged to report the barriers to treatment change; these were categorized and analysed by study staff. Multiple barriers were possible for one visit. Results: Eighty-three visits not in agreement with the TTT strategy were observed in 74 patients, during which 90 reported barriers to treatment adjustment were noted. Common barriers to adjusting treatment included patient preference in 37.1% of visits and elevated disease activity measure despite no objective evidence of active RA in 38.6% of visits. Conclusion: An elevated disease activity measure not reflective of RA disease activity and patient preference are the two leading barriers to treatment adjustment to TTT in RA. Understanding barriers to adherence should guide interventions aimed at using better markers of disease activity and improving alignment with patient preference, with the overarching goal of enhancing TTT adherence.
RCT Entities:
Objectives: Adherence to a treat to target (TTT) strategy is a recommended paradigm for RA; however, research shows there are many barriers to implementation. We conducted a trial to improve TTT implementation, and herein examine barriers to treatment adjustment within TTT among patient visits not in agreement with the TTT paradigm. Methods: Chart review assessed TTT implementation based on documentation of four items: designation of a treatment target, recording a disease activity measure, shared-decision making when applicable and adjusting treatment when disease activity was not at target. A treatment decision not in agreement with the TTT paradigm was defined as lack of treatment adjustment when disease activity was not at the pre-determined treatment target. Providers were encouraged to report the barriers to treatment change; these were categorized and analysed by study staff. Multiple barriers were possible for one visit. Results: Eighty-three visits not in agreement with the TTT strategy were observed in 74 patients, during which 90 reported barriers to treatment adjustment were noted. Common barriers to adjusting treatment included patient preference in 37.1% of visits and elevated disease activity measure despite no objective evidence of active RA in 38.6% of visits. Conclusion: An elevated disease activity measure not reflective of RA disease activity and patient preference are the two leading barriers to treatment adjustment to TTT in RA. Understanding barriers to adherence should guide interventions aimed at using better markers of disease activity and improving alignment with patient preference, with the overarching goal of enhancing TTT adherence.
Authors: Leslie R Harrold; J Timothy Harrington; Jeffrey R Curtis; Daniel E Furst; Mary Jane Bentley; Ying Shan; George Reed; Joel Kremer; Jeffrey D Greenberg Journal: Arthritis Rheum Date: 2012-03
Authors: Lydia G Schipper; Laura T C van Hulst; Richard Grol; Piet L C M van Riel; Marlies E J L Hulscher; Jaap Fransen Journal: Rheumatology (Oxford) Date: 2010-07-29 Impact factor: 7.580
Authors: Lydia G Schipper; Marloes Vermeer; Hillechiena H Kuper; Monique O Hoekstra; Cees J Haagsma; Alfons A Den Broeder; Piet van Riel; Jaap Fransen; Mart A F J van de Laar Journal: Ann Rheum Dis Date: 2011-12-30 Impact factor: 19.103
Authors: Sabrina Meyfroidt; Kristien Van der Elst; Diederik De Cock; Johan Joly; René Westhovens; Marlies Hulscher; Patrick Verschueren Journal: Patient Educ Couns Date: 2014-11-20
Authors: Josef S Smolen; Ferdinand C Breedveld; Gerd R Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Tore K Kvien; M Victoria Navarro-Compán; Susan Oliver; Monika Schoels; Marieke Scholte-Voshaar; Tanja Stamm; Michaela Stoffer; Tsutomu Takeuchi; Daniel Aletaha; Jose Louis Andreu; Martin Aringer; Martin Bergman; Neil Betteridge; Hans Bijlsma; Harald Burkhardt; Mario Cardiel; Bernard Combe; Patrick Durez; Joao Eurico Fonseca; Alan Gibofsky; Juan J Gomez-Reino; Winfried Graninger; Pekka Hannonen; Boulos Haraoui; Marios Kouloumas; Robert Landewe; Emilio Martin-Mola; Peter Nash; Mikkel Ostergaard; Andrew Östör; Pam Richards; Tuulikki Sokka-Isler; Carter Thorne; Athanasios G Tzioufas; Ronald van Vollenhoven; Martinus de Wit; Desirée van der Heijde Journal: Ann Rheum Dis Date: 2015-05-12 Impact factor: 19.103
Authors: Marloes Vermeer; Hillechiena H Kuper; Hein J Bernelot Moens; Monique Hoekstra; Marcel D Posthumus; Piet L C M van Riel; Mart A F J van de Laar Journal: Arthritis Res Ther Date: 2012-11-23 Impact factor: 5.156
Authors: Marieke M Ter Wee; Veerle Mh Coupé; Debby den Uyl; Birgit S Blomjous; Esmee Kooijmans; Pit Jsm Kerstens; Mike T Nurmohamed; Dirkjan van Schaardenburg; Alexandre E Voskuyl; Maarten Boers; Willem F Lems Journal: RMD Open Date: 2017-10-25
Authors: Justin K Owensby; Lang Chen; Ronan O'Beirne; Eric M Ruderman; Leslie R Harrold; Joshua A Melnick; Monika M Safford; Jeffrey R Curtis; Maria I Danila Journal: Arthritis Care Res (Hoboken) Date: 2020-07 Impact factor: 4.794
Authors: Bryant R England; Huifeng Yun; Lang Chen; Jared Vanderbleek; Kaleb Michaud; Ted R Mikuls; Jeffrey R Curtis Journal: Arthritis Care Res (Hoboken) Date: 2021-08-02 Impact factor: 5.178
Authors: Daniel H Solomon; Theodore Pincus; Nancy A Shadick; Jacklyn Stratton; Jack Ellrodt; Leah Santacroce; Jeffrey N Katz; Josef S Smolen Journal: Arthritis Care Res (Hoboken) Date: 2022-02-04 Impact factor: 5.178